{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:16:44Z","timestamp":1763057804896},"reference-count":94,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","theclinics.com","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.cld.2014.05.003","type":"journal-article","created":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T02:31:52Z","timestamp":1404873112000},"page":"543-560","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Renal Dysfunction in End-Stage Liver Disease and Post\u2013Liver Transplant"],"prefix":"10.1016","volume":"18","author":[{"given":"Marcelo S.","family":"Sampaio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suphamai","family":"Bunnapradist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.cld.2014.05.003_bib1","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1111\/j.1600-6143.2006.01526.x","article-title":"Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?","volume":"6","author":"Gonwa","year":"2006","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.cld.2014.05.003_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1523-1755.1998.00004.x","article-title":"Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation","volume":"54","author":"Fraley","year":"1998","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.cld.2014.05.003_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1523-1755.2005.00408.x","article-title":"Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy","volume":"68","author":"Wong","year":"2005","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.cld.2014.05.003_bib4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.cld.2014.05.003_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/lt.21682","article-title":"Acute kidney injury following liver transplantation: definition and outcome","volume":"15","author":"Barri","year":"2009","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2014.05.003_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2011.10.016","article-title":"Renal failure and cirrhosis: a systematic review of mortality and prognosis","volume":"56","author":"Fede","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2014.05.003_bib7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","author":"Martin-Llahi","year":"2011","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2014.05.003_bib8","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1600-6143.2010.03224.x","article-title":"Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues","volume":"10","author":"Schwarz","year":"2010","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.cld.2014.05.003_bib9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.cld.2014.05.003_bib10","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2012.04190.x","article-title":"Simultaneous liver-kidney transplantation summit: current state and future directions","volume":"12","author":"Nadim","year":"2012","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2014.05.003_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5414\/CNP70010","article-title":"Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease","volume":"70","author":"Hojs","year":"2008","journal-title":"Clin Nephrol"},{"issue":"6 Pt 1","key":"10.1016\/j.cld.2014.05.003_bib12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/clinchem\/48.6.850","article-title":"Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis","volume":"48","author":"Orlando","year":"2002","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.cld.2014.05.003_bib13","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/hep.26886","article-title":"Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis","volume":"59","author":"Souza","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2014.05.003_bib14","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2014.05.003_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2014.05.003_bib16","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2014.05.003_bib17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0016-5085(88)90441-6","article-title":"Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites","volume":"94","author":"Llach","year":"1988","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2014.05.003_bib18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.ajkd.2011.12.032","article-title":"Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis","volume":"59","author":"Fagundes","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.cld.2014.05.003_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MCC.0b013e32835ebb3a","article-title":"Renal interactions in liver dysfunction and failure","volume":"19","author":"Verna","year":"2013","journal-title":"Curr Opin Crit Care"},{"issue":"9","key":"10.1016\/j.cld.2014.05.003_bib20","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2014.05.003_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000084725","article-title":"Hepatorenal syndrome","volume":"23","author":"Guevara","year":"2005","journal-title":"Dig Dis"},{"issue":"12","key":"10.1016\/j.cld.2014.05.003_bib22","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.cgh.2013.03.018","article-title":"Acute kidney injury in patients with cirrhosis: perils and promise","volume":"11","author":"Belcher","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2014.05.003_bib23","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2014.05.003_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2014.05.003_bib25","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.cld.2014.05.003_bib26","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2014.05.003_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1159\/000355739","article-title":"Hepatorenal syndrome and novel advances in its management","volume":"37","author":"Fabrizi","year":"2013","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"10.1016\/j.cld.2014.05.003_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/039139880903200303","article-title":"Terlipressin for hepatorenal syndrome: a meta-analysis of randomized trials","volume":"32","author":"Fabrizi","year":"2009","journal-title":"Int J Artif Organs"},{"issue":"6","key":"10.1016\/j.cld.2014.05.003_bib29","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2014.05.003_bib30","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MCG.0b013e318188947c","article-title":"Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome","volume":"43","author":"Skagen","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2014.05.003_bib31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/hep.20559","article-title":"The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension","volume":"41","author":"Boyer","year":"2005","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2014.05.003_bib32","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3748\/wjg.15.1459","article-title":"Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis","volume":"15","author":"Lodhia","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2014.05.003_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.ajkd.2003.09.009","article-title":"Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials","volume":"43","author":"Alonso","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.cld.2014.05.003_bib34","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.amjcard.2003.08.059","article-title":"Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy","volume":"92","author":"Isenbarger","year":"2003","journal-title":"Am J Cardiol"},{"issue":"26","key":"10.1016\/j.cld.2014.05.003_bib35","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1056\/NEJMoa054209","article-title":"N-acetylcysteine and contrast-induced nephropathy in primary angioplasty","volume":"354","author":"Marenzi","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.cld.2014.05.003_bib36","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V93506","article-title":"Acute interstitial nephritis","volume":"9","author":"Michel","year":"1998","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cld.2014.05.003_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2014.74","article-title":"A\u00a0nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use","author":"Blank","year":"2014","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.cld.2014.05.003_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/nep.12226","article-title":"Omeprazole-induced acute interstitial nephritis: a possible Th1-Th17 mediated injury?","volume":"19","author":"Berney-Meyer","year":"2014","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"10.1016\/j.cld.2014.05.003_bib39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2125.2007.02927.x","article-title":"Proton pump inhibitor-induced acute interstitial nephritis","volume":"64","author":"Harmark","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.cld.2014.05.003_bib40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1440-1797.2006.00651.x","article-title":"Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases","volume":"11","author":"Simpson","year":"2006","journal-title":"Nephrology (Carlton)"},{"issue":"5","key":"10.1016\/j.cld.2014.05.003_bib41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cgh.2005.11.004","article-title":"Proton pump inhibitors and acute interstitial nephritis","volume":"4","author":"Geevasinga","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2014.05.003_bib42","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2010.89","article-title":"Acute interstitial nephritis","volume":"77","author":"Praga","year":"2010","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.cld.2014.05.003_bib43","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.ki.5002776","article-title":"Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis","volume":"73","author":"Gonzalez","year":"2008","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.cld.2014.05.003_bib44","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2008.53","article-title":"The treatment of acute interstitial nephritis: more data at last","volume":"73","author":"Appel","year":"2008","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.cld.2014.05.003_bib45","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/ndt\/14.10.2279","article-title":"Glomerular IgA deposition in liver disease","volume":"14","author":"Pouria","year":"1999","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.cld.2014.05.003_bib46","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-144-10-200605160-00007","article-title":"Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation","volume":"144","author":"McGuire","year":"2006","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.cld.2014.05.003_bib47","first-page":"68","article-title":"Experimental IgA nephropathy secondary to hepatocellular injury induced by dietary deficiencies and heavy alcohol intake","volume":"70","author":"Amore","year":"1994","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.cld.2014.05.003_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2006.09.015","article-title":"Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis","volume":"49","author":"Roccatello","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.cld.2014.05.003_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.03710708","article-title":"Hepatitis C infection and chronic renal diseases","volume":"4","author":"Perico","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.cld.2014.05.003_bib50","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.mcna.2009.03.003","article-title":"Renal failure in patients with cirrhosis","volume":"93","author":"Mackelaite","year":"2009","journal-title":"Med Clin North Am"},{"issue":"4","key":"10.1016\/j.cld.2014.05.003_bib51","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/j.ajkd.2003.11.020","article-title":"Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN","volume":"43","author":"Alric","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.cld.2014.05.003_bib52","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus","volume":"330","author":"Misiani","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.cld.2014.05.003_bib53","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jhep.2013.07.023","article-title":"Sofosbuvir-based interferon-free therapy for patients with HCV infection","volume":"59","author":"Asselah","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2014.05.003_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1208953","article-title":"Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C","volume":"368","author":"Gane","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.cld.2014.05.003_bib55","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.cld.2014.05.003_bib56","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1214854","article-title":"Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options","volume":"368","author":"Jacobson","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2014.05.003_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/hep.27151","article-title":"Cost analysis of sofosbuvir\/ribavirin versus sofosbuvir\/simeprevir for genotype 1 HCV in interferon ineligible\/intolerant individuals","author":"Hagan","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2014.05.003_bib58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1331\/JAPhA.2014.14513","article-title":"New drugs: simeprevir, sofosbuvir, and dolutegravir sodium","volume":"54","author":"Hussar","year":"2014","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"5","key":"10.1016\/j.cld.2014.05.003_bib59","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00535-014-0949-8","article-title":"Once-daily simeprevir with peginterferon and ribavirin for treatment-experienced HCV genotype 1-infected patients in Japan: the CONCERTO-2 and CONCERTO-3 studies","volume":"49","author":"Izumi","year":"2014","journal-title":"J\u00a0Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2014.05.003_bib60","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/ndt\/gfh469","article-title":"Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.cld.2014.05.003_bib61","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000077065","article-title":"Hepatitis B virus-associated nephropathy","volume":"24","author":"Bhimma","year":"2004","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1016\/j.cld.2014.05.003_bib62","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0016-5085(95)90343-7","article-title":"Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa","volume":"109","author":"Conjeevaram","year":"1995","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2014.05.003_bib63","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/j.1523-1755.2005.00591.x","article-title":"Lamivudine in hepatitis B-associated membranous nephropathy","volume":"68","author":"Tang","year":"2005","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.cld.2014.05.003_bib64","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1517\/13543780903241599","article-title":"Monotherapy versus combination therapy for the treatment of chronic hepatitis B","volume":"18","author":"Carey","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"10.1016\/j.cld.2014.05.003_bib65","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ki.2013.249","article-title":"Treatment of hepatitis B in patients with chronic kidney disease","volume":"84","author":"Pipili","year":"2013","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.cld.2014.05.003_bib66","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/TP.0b013e31818b22cc","article-title":"Analysis of kidney function and biopsy results in liver failure patients with renal dysfunction: a new look to combined liver kidney allocation in the post-MELD era","volume":"86","author":"Tanriover","year":"2008","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.cld.2014.05.003_bib67","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/TP.0b013e318168476d","article-title":"Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts","volume":"85","author":"Locke","year":"2008","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.cld.2014.05.003_bib68","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/TP.0b013e31821bad1b","article-title":"Simultaneous liver and kidney transplants: optimizing use of this double resource","volume":"91","author":"Chopra","year":"2011","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.cld.2014.05.003_bib69","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1600-6143.2008.02416.x","article-title":"Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK)","volume":"8","author":"Eason","year":"2008","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.cld.2014.05.003_bib70","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MOT.0b013e328338f638","article-title":"Combined liver and kidney transplantation","volume":"15","author":"Papafragkakis","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"issue":"11","key":"10.1016\/j.cld.2014.05.003_bib71","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/lt.20215","article-title":"Risk factors for renal dysfunction in the postoperative course of liver transplant","volume":"10","author":"Lebron Gallardo","year":"2004","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2014.05.003_bib72","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/sj.ki.5000216","article-title":"Risk factors of acute renal failure after liver transplantation","volume":"69","author":"Cabezuelo","year":"2006","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2014.05.003_bib73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ajt.12581","article-title":"OPTN\/SRTR 2012 annual data report: liver","volume":"14","author":"Kim","year":"2014","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2014.05.003_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2007.00739.x","article-title":"Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity","volume":"22","author":"Flechner","year":"2008","journal-title":"Clin Transplant"},{"issue":"8","key":"10.1016\/j.cld.2014.05.003_bib75","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/lt.23672","article-title":"Early use of renal-sparing agents in liver transplantation: a closer look","volume":"19","author":"Trotter","year":"2013","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2014.05.003_bib76","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/ajt.12543","article-title":"De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial","volume":"14","author":"Asrani","year":"2014","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.cld.2014.05.003_bib77","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/ajt.12615","article-title":"Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation","volume":"14","author":"Sterneck","year":"2014","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.cld.2014.05.003_bib78","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/ajt.12280","article-title":"Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study","volume":"13","author":"Saliba","year":"2013","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.cld.2014.05.003_bib79","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.TP.0000438635.44461.2e","article-title":"Safety of belatacept bridging immunosuppression in hepatitis C-positive liver transplant recipients with renal dysfunction","volume":"97","author":"LaMattina","year":"2014","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.cld.2014.05.003_bib80","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","article-title":"Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?","volume":"40","author":"Batts","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.cld.2014.05.003_bib81","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","article-title":"Thrombotic microangiopathy after renal transplantation in the United States","volume":"42","author":"Reynolds","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.cld.2014.05.003_bib82","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1523-1755.2002.00543.x","article-title":"Post-transplant hemolytic-uremic syndrome","volume":"62","author":"Ruggenenti","year":"2002","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.cld.2014.05.003_bib83","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1046\/j.1523-1755.1999.00492.x","article-title":"Cyclosporine-associated thrombotic microangiopathy in renal allografts","volume":"55","author":"Zarifian","year":"1999","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.cld.2014.05.003_bib84","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/TP.0b013e3181d2fec1","article-title":"Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network\/United Network for Organ Sharing database","volume":"89","author":"Kuo","year":"2010","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cld.2014.05.003_bib85","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.transproceed.2011.03.004","article-title":"Cardiovascular risk factors after liver transplantation: analysis of related factors","volume":"43","author":"Perez","year":"2011","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.cld.2014.05.003_bib86","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1600-6143.2010.03126.x","article-title":"Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study","volume":"10","author":"Watt","year":"2010","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2014.05.003_bib87","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1002\/lt.21903","article-title":"Long-term medical comorbidities and their management: hypertension\/cardiovascular disease","volume":"15","author":"Guckelberger","year":"2009","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.cld.2014.05.003_bib88","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/lt.21627","article-title":"Decline in native kidney function in liver transplant recipients is not associated with BK virus infection","volume":"14","author":"Salama","year":"2008","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2014.05.003_bib89","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1399-3062.2006.00155.x","article-title":"A\u00a0prospective cross-sectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction","volume":"8","author":"Barton","year":"2006","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.cld.2014.05.003_bib90","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/TP.0b013e318273fec4","article-title":"Hepatitis C virus and nonliver solid organ transplantation","volume":"95","author":"Carbone","year":"2013","journal-title":"Transplantation"},{"issue":"9916","key":"10.1016\/j.cld.2014.05.003_bib91","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(13)62121-2","article-title":"Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial","volume":"383","author":"Lawitz","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cld.2014.05.003_bib92","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"Sulkowski","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.cld.2014.05.003_bib93","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.2215\/CJN.02950410","article-title":"An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation","volume":"5","author":"Srinivas","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.cld.2014.05.003_bib94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/TP.0b013e31821c1e54","article-title":"Kidney transplantation after previous liver transplantation: analysis of the organ procurement transplant network database","volume":"92","author":"Gonwa","year":"2011","journal-title":"Transplantation"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326114000312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326114000312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T11:07:20Z","timestamp":1716980840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326114000312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1089326114000312"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2014.05.003","relation":{},"ISSN":["1089-3261"],"issn-type":[{"type":"print","value":"1089-3261"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal Dysfunction in End-Stage Liver Disease and Post\u2013Liver Transplant","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2014.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}